We are live on !
Find out more
Citizens Financial Group Portfolio holdings
AUM
$8.3B
Turnover
25.56%
1-Year Est. Return
27.66%
This Fund
S&P 500
This Quarter Est. Return
+15.91%
1 Year Est. Return
+27.66%
3 Year Est. Return
+83.7%
5 Year Est. Return
+92.76%
10 Year Est. Return
+380.95%
AUM
$8.3B
AUM Growth
+$1.11B
(+16%)
Cap. Flow
+$214M
Cap. Flow % of AUM
Cap. Flow %
2.58%
Top 10 Holdings %
Top 10 Hldgs %
34.47%
Holding
1,080
New
243
Increased
533
Reduced
215
Closed
33
Avg Time Held
2.7
years
Top 10 Avg Time Held
6.6
years
Top 20 Avg Time Held
5.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Bond ETF
BIV
|
+$43.7M |
| 2 |
WisdomTree Floating Rate Treasury Fund
USFR
|
+$15M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$13.6M |
| 4 |
BlackRock ETF Trust II iShares Short-Term California Muni Active ETF
CALI
|
+$11.9M |
| 5 |
Revolution Medicines
RVMD
|
+$10.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$29.8M |
| 2 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$16.9M |
| 3 |
Goldman Sachs
GS
|
+$14.2M |
| 4 |
Apple
AAPL
|
+$10.9M |
| 5 |
Honeywell
HON
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.45% |
| 2 | Technology | 18.37% |
| 3 | Financials | 8.99% |
| 4 | Communication Services | 6.26% |
| 5 | Industrials | 5.57% |
Similar funds
Citizens Financial Group's Q2 2026 Portfolio in Review
As of Q2 2026, Citizens Financial Group held 1,080 positions worth $8.3B, up 16% from $7.19B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Citizens Financial Group's Q2 2026 filing shows 243 new, 533 increased, 215 reduced and 33 closed positions. Its largest new stake was Revolution Medicines: 74,036 shares worth $13.9M. The largest sale was ExxonMobil, an estimated $29.8M.
By sector, the portfolio is most concentrated in Miscellaneous at 45% of assets, up from 45% a quarter earlier, followed by Technology and Financials.
- Citizens Financial Group's largest Q2 2026 buy was Revolution Medicines: 74,036 shares worth $13.9M.
- Citizens Financial Group added most to Vanguard Intermediate-Term Bond ETF in Q2 2026, an estimated $43.7M increase.
- Citizens Financial Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $29.8M.
- Citizens Financial Group fully exited Halozyme in Q2 2026, selling an estimated $1.67M.
- Citizens Financial Group's ten largest holdings make up 34% of its $8.3B portfolio in Q2 2026.
- Citizens Financial Group opened 243 new positions and closed 33 in Q2 2026.
- Citizens Financial Group's portfolio value rose 16% quarter-over-quarter to $8.3B.
Based on Citizens Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.